Reaction
Iron Overload reporting signals
As of the last recalculation, Iron Overload appears in 1,066 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DEFERASIROX (PRR 269.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Deferasirox | 273 | 269.9 | 272.7 |
| Eculizumab | 174 | 74.5 | 74.8 |
| Iron Sucrose | 29 | 61.0 | 61.2 |
| Erythropoietin | 52 | 51.9 | 52.0 |
| Ruxolitinib | 109 | 33.0 | 33.0 |
| Thiamine Hydrochloride | 19 | 30.3 | 30.4 |
| Ursosiol | 26 | 26.7 | 26.8 |
| Azacitidine | 37 | 25.2 | 25.2 |
| Ursodiol | 27 | 24.8 | 24.8 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 22.0 | 22.0 |
| Epoetin Alfa | 13 | 21.7 | 21.7 |
| Eltrombopag Olamine | 22 | 19.0 | 19.0 |
| Azacitidine For | 17 | 18.5 | 18.5 |
| Hydroxyurea | 19 | 17.8 | 17.9 |
| Darbepoetin Alfa | 43 | 16.2 | 16.2 |
| Ravulizumab | 10 | 14.6 | 14.6 |
| Desvenlafaxine Succinate | 18 | 13.2 | 13.2 |
| Paricalcitol | 9 | 12.5 | 12.5 |
| Thiotepa | 6 | 12.3 | 12.3 |
| Pegaspargase | 7 | 11.2 | 11.2 |
| Fludarabine Phosphate | 22 | 11.1 | 11.1 |
| Romiplostim | 8 | 10.4 | 10.5 |
| Granisetron | 5 | 9.3 | 9.4 |
| Voxelotor | 8 | 7.0 | 7.0 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 5.3 | 5.3 |